Skip to main content

Fall 14: Spätschäden – 45 Jahre, ♀, DM Typ 1, Menopause im 40. Lebensjahr, Osteoporose

  • Chapter
  • First Online:
Diabetes-Therapie – informiert entscheiden
  • 2341 Accesses

Zusammenfassung

Eine 45-jährige Diabetikerin mit Menopause im 40. Lebensjahr, einem HbA1c von 7,5 % und Osteoporose. Hängt die Osteoporose mit dem Typ-1-Diabetes zusammen, und gibt es eine spezifische Osteoporose Therapie für Typ-1-Diabetiker?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T et al (2000) Fracture risk reduction with alendronate in women with osteoporosis. J Clin Endocrinol Metab 85:4118–4124

    Article  CAS  Google Scholar 

  • Cauley JA, Robbins J, Chen Z et al (2003) Womens health initiative investigators Effects of estrogen plus progesterone on th erisk of farctures and bone mineral density. JAMA 290:1729–1738

    Article  CAS  Google Scholar 

  • Gambacciani M, Cappagli B, Ciaponi M et al (2008) Ultra low dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas 59:2–6

    Article  CAS  Google Scholar 

  • Kasperk C, Hillmeier J, Nöldge G, Grafe I, DaFonseca K, Raupp D, Bardenheuer H, Libicher M, Liegibel UM, Sommer U, Hilscher U, Pyerin W, Vetter M, Meinzer HP, Meeder PJ, Taylor RS, Nawroth P (2005) Treatment of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: a prospective nonrandomized controlled study. J Boen Min Res 20:604–612

    Article  Google Scholar 

  • Kasperk C, Grafe I, Schmitt S, Nöldge G, Weiss C, DaFonseca K, Hillmeier J, Libicher M, Sommer U, Rudofsky G, Meeder PJ, Nawroth P (2010) Three year outcomes afer kyphoplasty in patients with osteoporosis with painful vertebral fractures. J Vasc Interv Radiol 21:701–709

    Article  Google Scholar 

  • Kasperk C, Georgescu C, Nawroth P (2017) Diabetes mellitus and bone metabolism. Exp Clin Endocrinol Diab 125:213–217

    Article  CAS  Google Scholar 

  • Lange A, Kasperk C, Alövares L, Sauermann S, Braun S (2014) Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine 39:318–326

    Article  Google Scholar 

  • Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Mineral Res 27:2231–2237

    Article  Google Scholar 

  • Nguyen ND, Eisman JA, Nguyen V (2006) Anti hip fracture efficacy of bisphosphonates. J Bone Min Res 21:340–349

    Article  CAS  Google Scholar 

  • Riggs BL, Khosla S, Melton LJ (2002) Sex steroids and the consruction and conservation of the adult akeleton. Endocr Rev 23:279–302

    Article  CAS  Google Scholar 

  • Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) A Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta analysis. Lancet 370:657–666

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chrisitan Kasperk .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kasperk, C. (2018). Fall 14: Spätschäden – 45 Jahre, ♀, DM Typ 1, Menopause im 40. Lebensjahr, Osteoporose. In: Kihm, L., Kopf, S., Nawroth, P. (eds) Diabetes-Therapie – informiert entscheiden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55972-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55972-7_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55971-0

  • Online ISBN: 978-3-662-55972-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics